Subscribe to Email Alerts
Menu
Subscribe to Email Alerts
Home
About Us
Hemp Explained
CBD Explained
Vision & Purpose
Board of Directors
Our Executive Team
Corporate Governance
Operations
Americas
Europe
Australia
Investor Centre
ASX Announcements
Annual General Meeting
Presentations
Annual and Financial Reports
Shareholder Services
Share Price Information
Equity Plan Rules
Right to Receive Documents
Non-Renounceable Rights Issue Offer
Media Centre
Top Stories
Elixinol Wellness in the News
Media Contact Details
Science & Wellness
Contact Us
Subscribe to Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
ASX Announcements
Annual General Meeting
Presentations
Annual and Financial Reports
Shareholder Services
Share Price Information
Equity Plan Rules
Right to Receive Documents
Non-Renounceable Rights Issue Offer
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
29-Jul-2019
Elixinol partners with PharmaCare
23-Jul-2019
Elixinol continues to build Leadership team
22-Jul-2019
Global IP rights for microencapsulation technology acquired
18-Jul-2019
Final Directors Interest Notice - Linda McLeod
18-Jul-2019
Initial Directors Interest Notice - Stratos Karousos
17-Jul-2019
Nunyara Manufacturing Licence
16-Jul-2019
Leadership and Group Structure update
4-Jul-2019
MedVec Distribution Agreement Signed
12-Jun-2019
D&G Health Change of Substantial Holder
12-Jun-2019
Raw with Life Change of Substantial Holder
Previous
1
2
3
4
5
6
7
Next